A Study of Deflazacort (Emflaza®) in Participants With Duchenne Muscular Dystrophy (DMD)
Clinical trial NCT03642145 · WITHDRAWN
Trial details
- NCT number
- NCT03642145
- Sponsor
- PTC Therapeutics
- Status
- WITHDRAWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-10-31
- Primary completion
- 2021-07-31
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.